Jupiter Life Line Hospitals IPO GMP History
Jupiter Life Line Hospitals IPO has been listed on September 18, 2023 at a listing price of ₹973, against the issue price of ₹735 — a gain of ₹238 (+32.38%). The GMP peaked at ₹270 on 8 September 2023 and reached a low of ₹80 on 4 September 2023. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Jupiter Life Line Hospitals IPO raised ₹869.08 Cr. through its IPO at a price band of ₹695 to ₹735 per share, with a lot size of 20 shares. The IPO was open for subscription from 06 Sep 2023 to 08 Sep 2023.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 6:08 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 16 Sep 2023 | ₹ 240 | — | 33% | — | — |
| 15 Sep 2023 | ₹ 240 | — | 33% | — | — |
| 14 Sep 2023 | ₹ 240 | — | 33% | — | — |
| 13 Sep 2023 | ₹ 240 | — | 33% | — | — |
| 12 Sep 2023 | ₹ 240 | ▼ | 33% | — | — |
| 11 Sep 2023 | ₹ 250 | ▲ | 34% | — | — |
| 09 Sep 2023 | ₹ 240 | ▼ | 33% | — | — |
| 08 Sep 2023 | ₹ 270 | ▲ | 37% | — | — |
| 07 Sep 2023 | ₹ 220 | ▲ | 30% | — | — |
| 06 Sep 2023 | ₹ 215 | ▲ | 29% | — | — |
| 05 Sep 2023 | ₹ 200 | ▲ | 27% | — | — |
| 04 Sep 2023 | ₹ 80 | — | 11% | — | — |
| 02 Sep 2023 | ₹ 80 | — | 11% | — | — |
Jupiter Life Line Hospitals IPO dates
Key dates from opening to listing. Today is 11 November.
- Open 06 Sep 2023
- Close 08 Sep 2023
- Allotment 13 Sep 2023
- Refund/credit 14 Sep 2023
- Listing 18 Sep 2023
Jupiter Life Line Hospitals IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹735 |
|---|---|
| GMP-based estimate (pre-listing) | ₹975 (+32.7%) |
| Listing gain / loss | +₹238 per share |
| Listing date | 18 Sep, 2023 |
| Actual listing price | ₹973 (+32.38%) |
Is Jupiter Life Line Hospitals IPO GMP reliable?
Grey market premium for Jupiter Life Line Hospitals IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Jupiter Life Line Hospitals IPO full review for a fundamentals-based assessment before making any grey market trades.
Jupiter Life Line Hospitals IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Jupiter Life Line Hospitals IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Jupiter Life Line Hospitals IPO
Jupiter Life Line Hospitals Limited was incorporated at Mumbai on 18 November 2002. As per CRISIL, it is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area and western India.
It has operated for over 15 years and runs three hospitals at Thane, Pune and Indore under the Jupiter brand, with total capacity of 1,194 beds on 31 March 2023. It had 1,306 doctors, including specialists, physicians and surgeons.
It is building a multi-specialty hospital in Dombivli, Maharashtra, designed for over 500 beds, where construction began in April 2023.
The IPO was Rs 869.08 crore, with Rs 542.00 crore of fresh issue and Rs 327.08 crore of offer for sale by investors, promoter group members and other shareholders. Rs 510.16 crore was planned for repaying borrowings of the company and its material subsidiary.
Frequently asked
What is the GMP of Jupiter Life Line Hospitals IPO?
The current Grey Market Premium (GMP) of Jupiter Life Line Hospitals IPO is ₹ 240.
What is the Kostak Price of Jupiter Life Line Hospitals IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Jupiter Life Line Hospitals IPO is not available.
What is the Subject to Sauda Price of Jupiter Life Line Hospitals IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Jupiter Life Line Hospitals IPO?
Jupiter Life Line Hospitals IPO listed on September 18, 2023 at ₹973, against the issue price of ₹735 — a gain of +32.38%.
How did the GMP of Jupiter Life Line Hospitals IPO trend before listing?
The GMP of Jupiter Life Line Hospitals IPO was stable in its final days before listing. The GMP peaked at ₹270 on 8 September 2023. View the day-wise table above for the complete GMP history.
Explore Jupiter Life Line Hospitals IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
